FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041090731> ?p ?o ?g. }

• W2041090731 endingPage "86" @default.
• W2041090731 startingPage "85" @default.
• W2041090731 abstract "Editorials1 January 1992Combination Therapy for HIV Infection: Getting CloserAnthony S. Fauci, MDAnthony S. Fauci, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-116-1-85 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptPersons infected with the human immunodeficiency virus (HIV), their health care providers, and clinical investigators have recently expressed considerable interest in the possibility that combination therapy with antiretroviral agents might prove more beneficial than treatment with these agents used alone. The intensity of this interest has been heightened by the fact that zidovudine, which, until recently, was the only drug licensed for the treatment of HIV infection, has proved unsuccessful in completely suppressing virus replication (1) and in controlling disease progression over extended periods (2). In addition, virus isolates with diminished in-vitro sensitivity to zidovudine have emerged (3, 4) after...References1. HoMoudgilAlam DTM. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med. 1989;321:1621-5. CrossrefMedlineGoogle Scholar2. FischlRichmanCauseyGriecoBrysonMildvan MDDMYD. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group. JAMA. 1989;262:2405-10. CrossrefMedlineGoogle Scholar3. LarderDarbyRichman BGD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 1989;243:1731-4. CrossrefMedlineGoogle Scholar4. RichmanGrimesLagakos DJS. Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. J Acquir Immun Defic Syndr. 1990;3:743-6. MedlineGoogle Scholar5. Fauci A. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science. 1988;239:617-22. CrossrefMedlineGoogle Scholar6. MengFischlBootaSpectorBennettBassiakos TMASDY. Combination therapy with zidovudine and dideoxycytidine in patients with advanced HIV disease. A phase I/II study. Ann Intern Med. 1991;116:13-20. LinkGoogle Scholar7. Fauci A. ddI—a good start, but still phase I. N Engl J Med. 1990;322:1386-8. CrossrefMedlineGoogle Scholar8. LambertSeidlinReichmanPlankLavertyMorse JMRCMG. 2,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. N Engl J Med. 1990;322:1333-40. CrossrefMedlineGoogle Scholar9. CooleyKunchesSaundersSaundersRitterPerkins TLCCJC. Once daily administration of 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a phase I trial. N Engl J Med. 1990;322:1340-5. CrossrefMedlineGoogle Scholar10. TornevikEriksson YS. 2′,3′-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3′-azido-3′deoxythymidine and thymidine. Mol Pharmacol. 1990;38:237-43. MedlineGoogle Scholar11. EronHirschMerrillChouJohnson JMDTV. Synergistic inhibition of HIV-1 by the combination of zidovudine (AZT) and 2′,3′-dideoxycytidine (ddC) in vitro. [Abstract]. Seventh International Conference on AIDS, Florence, Italy, 16-21 June 1991. Google Scholar12. St. ClairMartinTudor-WilliamsBachVavroKing MJGMCD. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science. 1991;253:1557-9. CrossrefMedlineGoogle Scholar13. KovacsDeytonDaveyFalloonZunichLee JLRJKD. Combined zidovudine and interferon-a therapy in patients with Kaposi sarcoma and acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989;111:280-7. LinkGoogle Scholar14. KrownGoldNeidzwieckiBundowFlomenbergGansbacher SJDDNB. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1990;112:812-21. LinkGoogle Scholar15. FischlUttamchandaniResnickAgarwalFletcherPatrone-Reese MRLRMJ. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon alpha nl and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr. 1991;4:1-10. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: National Institutes of Health Bethesda, MD 20892 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByIntervening on Conflict, Parental Bonds, and Sexual Risk Acts among Adolescent Children of Mothers Living with HIVRetinal Disease in HIV-infected PatientsSocial Support, Medication Compliance and HIV/AIDSGene TherapyPharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.Combination Antiretroviral Therapy for HIV InfectionChapter 14. HIV Protease InhibitorsA Study of the Safety and Survival of the Adoptive Transfer of Genetically Marked Syngeneic Lymphocytes in HIV-infected Identical TwinsZidovudine: Five Years LaterGavin X. McLeod, MD, Scott M. Hammer, MDTreatment of HIV infection in infants and childrenThe Pharmacological Treatment of Human Immunodeficiency Virus Infection 1 January 1992Volume 116, Issue 1Page: 85-86KeywordsAllergy and immunologyAntiretroviral therapyAntiretroviralsDrugsHIVHIV infectionsHealth care providersInfectious diseases Issue Published: 1 January 1992 PDF DownloadLoading ..." @default.
• W2041090731 created "2016-06-24" @default.
• W2041090731 creator A5031736334 @default.
• W2041090731 date "1992-01-01" @default.
• W2041090731 modified "2023-10-18" @default.
• W2041090731 title "Combination Therapy for HIV Infection: Getting Closer" @default.
• W2041090731 cites W1988763067 @default.
• W2041090731 cites W2006959383 @default.
• W2041090731 cites W2028143521 @default.
• W2041090731 cites W2057054797 @default.
• W2041090731 cites W2065114401 @default.
• W2041090731 cites W2086462809 @default.
• W2041090731 cites W2132871317 @default.
• W2041090731 cites W2151593978 @default.
• W2041090731 cites W2318770038 @default.
• W2041090731 cites W2325115797 @default.
• W2041090731 cites W2325532246 @default.
• W2041090731 cites W4317563663 @default.
• W2041090731 doi "https://doi.org/10.7326/0003-4819-116-1-85" @default.
• W2041090731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1309202" @default.
• W2041090731 hasPublicationYear "1992" @default.
• W2041090731 type Work @default.
• W2041090731 sameAs 2041090731 @default.
• W2041090731 citedByCount "11" @default.
• W2041090731 countsByYear W20410907312014 @default.
• W2041090731 crossrefType "journal-article" @default.
• W2041090731 hasAuthorship W2041090731A5031736334 @default.
• W2041090731 hasConcept C126322002 @default.
• W2041090731 hasConcept C159047783 @default.
• W2041090731 hasConcept C203014093 @default.
• W2041090731 hasConcept C2522874641 @default.
• W2041090731 hasConcept C2776452011 @default.
• W2041090731 hasConcept C2776999253 @default.
• W2041090731 hasConcept C2779134260 @default.
• W2041090731 hasConcept C2780035454 @default.
• W2041090731 hasConcept C2780216070 @default.
• W2041090731 hasConcept C2780727368 @default.
• W2041090731 hasConcept C3013748606 @default.
• W2041090731 hasConcept C71924100 @default.
• W2041090731 hasConcept C98274493 @default.
• W2041090731 hasConceptScore W2041090731C126322002 @default.
• W2041090731 hasConceptScore W2041090731C159047783 @default.
• W2041090731 hasConceptScore W2041090731C203014093 @default.
• W2041090731 hasConceptScore W2041090731C2522874641 @default.
• W2041090731 hasConceptScore W2041090731C2776452011 @default.
• W2041090731 hasConceptScore W2041090731C2776999253 @default.
• W2041090731 hasConceptScore W2041090731C2779134260 @default.
• W2041090731 hasConceptScore W2041090731C2780035454 @default.
• W2041090731 hasConceptScore W2041090731C2780216070 @default.
• W2041090731 hasConceptScore W2041090731C2780727368 @default.
• W2041090731 hasConceptScore W2041090731C3013748606 @default.
• W2041090731 hasConceptScore W2041090731C71924100 @default.
• W2041090731 hasConceptScore W2041090731C98274493 @default.
• W2041090731 hasIssue "1" @default.
• W2041090731 hasLocation W20410907311 @default.
• W2041090731 hasLocation W20410907312 @default.
• W2041090731 hasOpenAccess W2041090731 @default.
• W2041090731 hasPrimaryLocation W20410907311 @default.
• W2041090731 hasRelatedWork W1999388526 @default.
• W2041090731 hasRelatedWork W2011678344 @default.
• W2041090731 hasRelatedWork W2013332448 @default.
• W2041090731 hasRelatedWork W2044995509 @default.
• W2041090731 hasRelatedWork W2079658845 @default.
• W2041090731 hasRelatedWork W2084135183 @default.
• W2041090731 hasRelatedWork W2132817149 @default.
• W2041090731 hasRelatedWork W2135124387 @default.
• W2041090731 hasRelatedWork W2142378830 @default.
• W2041090731 hasRelatedWork W2401386503 @default.
• W2041090731 hasVolume "116" @default.
• W2041090731 isParatext "false" @default.
• W2041090731 isRetracted "false" @default.
• W2041090731 magId "2041090731" @default.
• W2041090731 workType "article" @default.